Welcome to the European Forum for Good Clinical Practice
Activities  >  Events and Activities  >  EFGCP/DIA Better Medicines for Children Conference
EFGCP/DIA Better Medicines for Children Conference
Global Paediatric Drug Development Challenges & Solutions - The Path Forward
18 & 19 October 2021Add to calendar
Virtual ConferenceSee on map
DescriptionProgrammeFacultyPractical Information

The Paediatric “Better Medicines for Children” Conference is an annual flagship event providing a unique opportunity to share best practice updates and a truly global outreach. Despite a challenging environment, and the need to meet virtually, we believe have been able to organise a dynamic, innovative, and highly engaging conference to inform our delegates of the latest scientific and regulatory developments.

Download the Programme in PDF Version.

This year the conference will focus on Global Paediatric Development, its challenges and solutions. To this effect, the conference brings together not only distinguished speakers from all around the world but also all the stakeholders involved, namely regulators, HTA body and payer representatives, industry, academia and patient representatives.

While focusing on paediatric research, i.e. what is happening, and how the future could look, Day One will bring regulators and patient representatives from around the world to discuss the impact of existing European and US paediatric regulations on paediatric R&D. The Programme Committee is proud to welcome Fabio d’Atri who will update us on the work done by the European Commission to revisit the Paediatric Regulation. He will be joined by regulators from the UK MHRA and the US FDA, while a panel moderated by a WHO representative will include regulators from Japanese PMDA, Chinese NMPA and Brazilian ANVISA, all involved in the review of paediatric dossiers and matters.

Active engagement of conference participants will be welcomed in Breakout Sessions to discuss challenges and identify solutions on what could be done to optimise children access to new medicines, with a focus on:
  • 1. Public Private Partnerships
  • 2. Paediatric Formulations
  • 3. Remote Decentralised Clinical Trials.

  • At the end of Day 1, a fireside chat moderated by Elin Haf Davies (Aparito) will be the opportunity to hear from Dr Koen Norga (PDCO chair) and Dr Angeliki Siapkara (MHRA and former UK representative on PDCO) about their respective activities and priorities; and also to discuss the changing European landscape post-Brexit.

    Day 2 will focus on hot topics in paediatric R&D showing the value of multi-stakeholders’ collaboration to address gaps in scientific knowledge, explore new innovative development avenues, and foster paediatric drug development.

    The programme committee looks forward to welcoming you all to the conference for a global educational and networking event that will present a unique opportunity to learn from each other, to meet and interact with colleagues from all parts of the world.

    Thank you for your attendance.
    Ask us
    If you have any question, send us an email to
    Follow us
    European Forum for Good Clinical Practice
    Rue de Washington 40
    B-1050 Brussels - Belgium
    Tel : +32 2 732 87 83
    TVA : BE 0457 666 685